Cyclin-dependent kinase 4/6 inhibitors palbociclib or ribociclib combined with endocrine therapy and radiation therapy for patients with metastatic breast cancer

被引：0
|
作者：
Ratosa, I. [1 ]
Scoccimarro, E. [2 ,3 ]
Dominici, L. [2 ,3 ]
Orazem, M. [1 ]
Steinacher, M. [4 ]
Aquilano, M. [2 ,3 ]
Cerbai, C. [2 ,3 ]
Desideri, I. [2 ,3 ]
Marinko, T. [1 ]
Livi, L. [2 ,3 ]
Meattini, I. [2 ,3 ]
机构：
[1] Inst Oncol, Div Radiat Oncol, Ljubljana, Slovenia
[2] Univ Florence, Dept Expt & Clin Biomed Sci M Serio, Florence, Italy
[3] Azienda Osped Univ Careggi, Radiat Oncol Unit, Dept Oncol, Florence, Italy
[4] Univ Med Ctr Maribor, Dept Oncol, Maribor, Slovenia
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
262
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [21] Cyclin-dependent kinase 4/6 inhibition in cancer therapy
    Johnson, Neil
    Shapiro, Geoffrey I.
    CELL CYCLE, 2012, 11 (21) : 3913 - 3913
  • [22] Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer
    Husinka, Lakyn
    Koerner, Pamela H.
    Miller, Rick T.
    Trombatt, William
    JOURNAL OF DRUG ASSESSMENT, 2021, 10 (01) : 27 - 34
  • [23] Cyclin-dependent kinase 4/6 inhibitors for the management of advanced or metastatic breast cancer in women
    Cersosimo, Robert J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (16) : 1183 - 1202
  • [24] Differences of cyclin-dependent kinase 4/6 inhibitor, palbociclib and abemaciclib, in breast cancer
    Tamura, Kenji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (11) : 993 - 998
  • [25] Cyclin-Dependent Kinase 4/6 Inhibitors Against Breast Cancer
    Hassan, Mohammed Al-Kassim
    Ates-Alagoz, Zeynep
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (04) : 412 - 428
  • [26] Cyclin-dependent kinase 4 and 6 inhibitors in breast cancer treatment
    Zhengfei Guo
    Richard W. Dong
    Yusheng Wu
    Shengli Dong
    Suresh K. Alahari
    Oncogene, 2025, 44 (17) : 1135 - 1152
  • [27] Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer
    Takahashi, Kaori
    Uozumi, Ryuji
    Mukohara, Toru
    Hayashida, Tetsu
    Iwabe, Midori
    Iihara, Hirotoshi
    Kusuhara-Mamishin, Kanako
    Kitagawa, Yuko
    Tsuchiya, Masami
    Kitahora, Mika
    Nagayama, Aiko
    Kosaka, Shinkichi
    Asano-Niwa, Yoshimi
    Seki, Tomoko
    Ohnuki, Koji
    Suzuki, Akio
    Ono, Fumiko
    Futamura, Manabu
    Kawazoe, Hitoshi
    Nakamura, Tomonori
    ONCOLOGIST, 2024, 29 (06): : e741 - e749
  • [28] Adverse Cardiovascular Events Associated With Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer
    Fradley, Michael G.
    Nguyen, Nam H. K.
    Madnick, David
    Chen, Yiqing
    DeMichele, Angela
    Makhlin, Igor
    Dent, Susan
    Lefebvre, Benedicte
    Carver, Joseph
    Upshaw, Jenica N.
    DeRemer, David
    Ky, Bonnie
    Guha, Avirup
    Gong, Yan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (12):
  • [29] Cyclin-dependent kinase 7 inhibitors in cancer therapy
    Wang, Minmin
    Wang, Tianyu
    Zhang, Xiangyu
    Wu, Xiaoxing
    Jiang, Sheng
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 813 - 833
  • [30] Efficacy and toxicity of endocrine therapy plus cyclin-dependent kinases 4/6 inhibitors (iCDK4/6) in metastatic breast cancer patients according to gBRCA status
    Bruno, L. I.
    Costanzo, M. V.
    Ostinelli, C. A.
    Nervo, A. A.
    Nadal, J.
    Colo, F.
    Loza, J.
    Loza, C. M.
    Ponce, C.
    Fabiano, V.
    Blanco, A. G.
    Perez de la Puente, C.
    Chacon, R. D.
    ANNALS OF ONCOLOGY, 2018, 29 : 98 - 98
12345